GANESH BAVIKATTE

Dr. GANESH BAVIKATTE


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Journal of Central Nervous System Disease
Verified
Journal Article
Open access
PDF file
GBGANESH BAVIKATTE
GANESH BAVIKATTE
GSGanesh Subramanian
Ganesh Subramanian
Stephen Andrew AshfordStephen Andrew Ashford
Stephen Andrew Ashford
RARhoda Allison
Rhoda Allison
DHDawn Hicklin
Dawn Hicklin
Stroke patients with spasticity usually require long-lasting care and interventions but frequently report that outpatient and community treatment is limited, reflecting a significant unmet need in health and social care provision. Rehabilitation and spasticity management services are essential for patient recovery, with improvements in both activity and participation reducing the burden on patients, family and society. Current clinical guidance provides scope for improvements in both post-stroke management and spasticity prevention. However, access to specialist services can be limited and the patient journey does not always match national recommendations. Identification of spasticity and its predictors and lack of subsequent referral to rehabilitation or specialist spasticity services are key issues in the management of post-stroke spasticity. Implementation of a traffic light classification system prioritises patients at an increased risk of spasticity and promotes early and consistent management across the spectrum of primary and secondary care. The proposed system is based on clinical evidence, expert consensus and recent clinical guidelines. It provides simple and straightforward criteria for management, multidisciplinary consultation and referral to specialist spasticity services, with patients allocated by monitoring requirements and a low (green/periodic monitoring), medium (amber/routine referral) or high risk (red/urgent referral) of spasticity.

22 August 2021 in Toxins
Verified
Journal Article
Open access
PDF file
GBGANESH BAVIKATTE
GANESH BAVIKATTE
LJLuis Jorge Jacinto
Luis Jorge Jacinto
TDThierry Deltombe
Thierry Deltombe
JWJörg Wissel
Jörg Wissel
The COVID-19 pandemic severely impacted the function of medical facilities and rehabilitation services worldwide, including toxin services delivering Botulinum toxin treatments for neuromuscular conditions such as spasticity, dystonia, and sialorrhea. The aim of this paper is to understand how toxin services have dealt with the situation and what strategies have been adopted to continue services. The recommendations are based on a virtual round table held with toxin services experts from different European countries who shared their experiences and discussed the best practices. The challenges for toxin services were reviewed based on the experts’ experiences and on relevant literature from 2020 and 2021. A set of recommendations and best practices were compiled, focusing firstly on guidance for clinical practice, including assessing patients’ health and risk status and the urgency of their treatment. Secondly, it was discussed how patients on botulinum toxin therapy can be cared for and supported during the pandemic, and how modern technology and tele-medicine platforms can be generally used to optimize effectiveness and safety of toxin treatments. The technological advances prompted by the COVID-19 crisis can result in better and more modern patient care in the future.

1 January 2012 in JPO Journal of Prosthetics and Orthotics
Verified
Journal Article
Closed access
GBGANESH BAVIKATTE
GANESH BAVIKATTE
JKJai Ma Kulkarni
Jai Ma Kulkarni
FCFouzia Bsc Choukairi
Fouzia Bsc Choukairi
VLVivien Md Lees
Vivien Md Lees